Company intelligence / Profile preview

MilanaPharm

Ownership: Private
Development stage: Other

Overview

MilanaPharm developed a proprietary drug delivery platform, which has been licensed to others for use in women's health and urological indications. Hammock Pharmaceuticals and subsequent partners have pursued clinical and commercial paths for products utilizing MilanaPharm’s platform.

Therapeutic areas: Men's HealthInfectious DiseasesWomen's Health
Modalities: Drug delivery platform
Industry: Drug Discovery Services

Partnerships

Hammock Pharmaceuticals (licensed women's health and urology platform)Dare Bioscience (global rights/licensee of MilanaPharm-originated product)

Beyond the preview

Go deeper on MilanaPharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MilanaPharm.

Explore the full profile